Skip to main content

CITIGROUP INC

Position in KNSA — Kiniksa Pharmaceuticals International, plc

CIK 831001 NEW YORK, NY

Position in KNSA

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$2,590,805
+$967,477 QoQ
Shares Held
40,513
+20.2% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#86
of 266 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KNSA Over Time

Shares Held

Position Value (USD)

Derivatives in KNSA

reported options exposure · as of Mar 31, 2025
CallValue
$1,265,970
CallShares
57,000
PutValue
$1,265,970
PutShares
57,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $573,447,136 across 59 Drug Manufacturers - Specialty & Generic names. KNSA ranks #20 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in KNSA

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,590,805 40,513
2026-03-31 $1,623,328 33,714
2025-12-31 $69,836 1,693
2025-09-30 $379,135 9,764
2025-06-30 $1,472,098 53,202
2025-03-31 $1,265,970 57,000
2025-03-31 $735,304 33,107
2025-03-31 $1,265,970 57,000
2024-12-31 $1,127,460 57,000
2024-12-31 $1,216,112 61,482
2024-12-31 $1,127,460 57,000
2024-09-30 $792,082 31,696
2024-06-30 $147,380 7,894